{rfName}

Indexed in

License and use

Altmetrics

Grant support

The authors are grateful to the patients and their families for participating in the project. They also thank all research personnel involved in the GROUP project, in particular J. van Baaren, E. Veermans, G. Driessen, T. Driesen, E. van't Hag and J. de Nijs. All the DNA samples from Turkey were provided by the Ankara University Brain Research Center Biobank, that was supported by Ankara University Scientific Research Projects Coordination Unit (project no. 10A6055003, 2010) .

Analysis of institutional authors

Lopez Saiz, GemmaAuthorBernardo MAuthorMezquida GAuthorAmoretti SAuthorAguilar EjAuthor

Share

September 22, 2021
Publications
>
Article
No

Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study

Publicated to:Progress In Neuro-Psychopharmacology & Biological Psychiatry. 113 110440- - 2022-03-08 113(), DOI: 10.1016/j.pnpbp.2021.110440

Authors: Fusar-Poli, Laura; Pries, Lotta-Katrin; van Os, Jim; Erzin, Gamze; Delespaul, Philippe; Kenis, Gunter; Luykx, Juryen J; Lin, Bochao D; Richards, Alexander L; Akdede, Berna; Binbay, Tolga; Altinyazar, Vesile; Yalincetin, Berna; Gumus-Akay, Guvem; Cihan, Burgin; Soygur, Haldun; Ulas, Halis; Cankurtaran, Eylem Sahin; Kaymak, Semra Ulusoy; Mihaljevic, Marina M; Andric-Petrovic, Sanja; Mirjanic, Tijana; Bernardo, Miguel; Mezquida, Gisela; Amoretti, Silvia; Bobes, Julio; Saiz, Pilar A; Garcia-Portilla, Maria Paz; Sanjuan, Julio; Aguilar, Eduardo J; Santos, Jose Luis; Jimenez-Lopez, Estela; Arrojo, Manuel; Carracedo, Angel; Lopez, Gonzalo; Gonzalez-Penas, Javier; Parellada, Mara; Maric, Nadja P; Atbasoglu, Cem; Ucok, Alp; Alptekin, Koksal; Saka, Meram Can; Aguglia, Eugenio; Arango, Celso; O'Donovan, Michael; Rutten, Bart P F; Guloksuz, Sinan

Affiliations

Adnan Menderes Univ, Fac Med, Dept Psychiat, Aydin, Turkey - Author
Adnan Menderes Üniversitesi - Author
Ankara Ataturk Research and Training Hospital - Author
Ankara Univ, Brain Res Ctr, Ankara, Turkey - Author
Ankara Univ, Sch Med, Dept Physiol, Ankara, Turkey - Author
Ankara Univ, Sch Med, Dept Psychiat, Ankara, Turkey - Author
Ankara Universitesi - Author
Ataturk Training & Res Hosp, Psychiat Clin, Ankara, Turkey - Author
Belgrade University School of Medicine - Author
Biomed Res Networking Ctr Mental Hlth CIBERSAM, Barcelona, Spain - Author
Biomedical Research Networking Centre in Mental Health (CIBERSAM) - Author
Cardiff Univ, Div Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff, Wales - Author
Cardiff University School of Medicine - Author
Clin Ctr Serbia, Psychiat Clin, Belgrade, Serbia - Author
Complejo Hosp Univ Santiago de Compostela, Inst Invest Sanitaria, Dept Psychiat, Santiago De Compostela, Spain - Author
Complejo Hospitalario Universitario de Santiago - Author
Dokuz Eylul Univ, Fac Med, Dept Psychiat, Izmir, Turkey - Author
Dokuz Eylul Univ, Grad Sch Hlth Sci, Dept Neurosci, Izmir, Turkey - Author
Dokuz Eylul Universitesi - Author
Dokuz Eylul Universitesi Tip Fakultesi - Author
FACT, Mondriaan Mental Hlth, Maastricht, Netherlands - Author
Facultad de Medicina y Ciencias de la Salud - Author
Fundación Pública Galega de Medicina Xenómica-SERGAS - Author
GGNet Mental Health - Author
GGNet Mental Hlth, Apeldoorn, Netherlands - Author
Güven Çayyolu Healthcare Campus - Author
Guven Cayyolu Healthcare Campus, Ankara, Turkey - Author
Hosp Virgen Luz, Dept Psychiat, Cuenca, Spain - Author
Hospital Clínico Universitario de Valencia - Author
Hospital General Universitario Gregorio Marañón - Author
Hospital Virgen de La Luz de Cuenca - Author
IDIS, Fdn Publ Galega Med Xenom SERGAS, Santiago De Compostela, Spain - Author
Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain - Author
Inst Invest Sanitaria Principado Asturias, Oviedo, Spain - Author
Inst Mental Hlth, Belgrade, Serbia - Author
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - Author
Institut za mentalno zdravlje - Author
Instituto de Investigación Sanitaria del Principado de Asturias - Author
Istanbul Tip Fakultesi - Author
Istanbul Univ, Fac Med, Dept Psychiat, Istanbul, Turkey - Author
King's College London - Author
Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England - Author
Klinicki Centar Srbije - Author
Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Med Ctr, Maastricht, Netherlands - Author
Mental Health Services of Principado de Asturias (SESPA) - Author
Mental Hlth Serv Principado Asturias, Oviedo, Spain - Author
Middle East Tech Univ, Dept Psychol, Ankara, Turkey - Author
Middle East Technical University (METU) - Author
Mondriaan Mental Health - Author
Neurosci & Neurotechnol Ctr Excellence NOROM, Ankara, Turkey - Author
Neuroscience and Neurotechnology Center of Excellence (NÖROM) - Author
Special Hosp Psychiat Disorders Kovin, Kovin, Serbia - Author
Special Hospital for Psychiatric Disorders Kovin - Author
Turkish Federat Schizophrenia Assoc, Ankara, Turkey - Author
Turkish Federation of Schizophrenia Associations - Author
Univ Barcelona, Hosp Clin Barcelona, Barcelona Clin Schizophrenia Unit, Neurosci Inst, Barcelona, Spain - Author
Univ Belgrade, Fac Med, Belgrade, Serbia - Author
Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain - Author
Univ Catania, Psychiat Unit, Dept Clin & Expt Med, Catania, Italy - Author
Univ Complutense, Hosp Gen Univ Gregorio Maranon, Dept Child & Adolescent Psychiat, Inst Psychiat & Mental Hlth,IiSGM,Sch Med, Madrid, Spain - Author
Univ Hlth Sci Ankara Diskapi Training & Res Hosp, Dept Psychiat, Ankara, Turkey - Author
Univ Oviedo, Sch Med, Dept Psychiat, Oviedo, Spain - Author
Univ Santiago de Compostela, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Grp Med Genom, Santiago De Compostela, Spain - Author
Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Psychiat, Utrecht, Netherlands - Author
Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Translat Neurosci, Utrecht, Netherlands - Author
Univ Valencia, Hosp Clin Univ Valencia, INCLIVA, Sch Med,Dept Psychiat, Valencia, Spain - Author
Universidad de Castilla-La Mancha - Author
Universidad de Santiago de Compostela - Author
Universita degli Studi di Catania - Author
Universitat de Barcelona - Author
Universiteit Maastricht - Author
University Medical Center Utrecht - Author
University of Health Sciences - Author
Yale School of Medicine - Author
Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA - Author
See more

Abstract

Social cognition impairments, such as facial emotion recognition (FER), have been acknowledged since the earliest description of schizophrenia. Here, we tested FER as an intermediate phenotype for psychosis using two approaches that are indicators of genetic risk for schizophrenia: the proxy-genetic risk approach (family design) and the polygenic risk score for schizophrenia (PRS-SCZ).The sample comprised 2039 individuals with schizophrenia, 2141 siblings, and 2049 healthy controls (HC). The Degraded Facial Affect Recognition Task (DFAR) was applied to measure the FER accuracy. Schizotypal traits in siblings and HC were assessed using the Structured Interview for Schizotypy-Revised (SIS-R). The PRS-SCZ was trained using the Psychiatric Genomics Consortium results. Regression models were applied to test the association of DFAR with psychosis risk, SIS-R, and PRS-SCZ.The DFAR-total scores were lower in individuals with schizophrenia than in siblings (RR?=?0.97 [95% CI 0.97, 0.97]), who scored lower than HC (RR?=?0.99 [95% CI 0.99-1.00]). The DFAR total score was negatively associated with SIS-R total scores in siblings (B?=?-2.04 [95% CI -3.72, -0.36]) and HC (B?=?-2.93 [95% CI -5.50, -0.36]). Different patterns of association were observed for individual emotions. No significant associations were found between DFAR scores and PRS-SCZ.Our findings based on a proxy genetic risk approach suggest that FER deficits may represent an intermediate phenotype for schizophrenia. However, a significant association between FER and PRS-SCZ was not found. In the future, genetic mechanisms underlying FER phenotypes should be investigated trans-diagnostically.Copyright © 2018. Published by Elsevier Inc.

Keywords

associationemotiongenetic riskimputationindividualspolygenic riskpolygenic risk scorereliabilityschizophreniaschizotypal traitssocial cognitionstructured interviewunaffected siblingsEmotionPolygenic risk scorePolygenic risk scoresSchizophreniaSchizotypal traitsSocial cognition

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Progress In Neuro-Psychopharmacology & Biological Psychiatry due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 44/278, thus managing to position itself as a Q1 (Primer Cuartil), in the category Pharmacology & Pharmacy.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 1.93. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Field Citation Ratio (FCR) from Dimensions: 4.81 (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-04, the following number of citations:

  • WoS: 15
  • Europe PMC: 3

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-04:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 63.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 63 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 7.25.
  • The number of mentions on the social network X (formerly Twitter): 13 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Italy; Netherlands; Serbia; Turkey; United Kingdom; United States of America.